journal article·2023-02Open access

Encapsulation of Platinum Prodrugs into PC7A Polymeric Nanoparticles Combined with Immune Checkpoint Inhibitors for Therapeutically Enhanced Multimodal Chemotherapy and Immunotherapy by Activation of the STING Pathway

Xiangjie Gao, Guanxiong Lei, Bin Wang, Zhong Deng, Johannes Karges, Haihua Xiao, Donghui Tan

Advanced Science· Volume 10· Issue 4

Abstract

Abstract Tumor immunotherapy has emerged as one of the most promising therapeutic methods to treat cancer. Despite its clinical application, the immunosuppressive tumor microenvironment compromises the therapeutic efficiency of this technique. To overcome this limitation, many research efforts have been devoted to the development of agents that reprogram the immunosuppressive tumor microenvironment through novel mechanisms. Over the last decade, compounds that intervene through the immunogenic stimulator of interferon genes (STING) pathway have emerged with potential for clinical development. Herein, the encapsulation of chemotherapeutic platinum complexes with a polymer with a cyclic seven‐membered ring (PC7A)‐based polymer into pH‐responsive nanoparticles for multimodal therapeutically enhanced chemotherapy and immunotherapy is presented. This study represents the first nanomaterial with a dual activation mechanism of the STING pathway through DNA fragmentation as well as PC7A binding. The combination of these nanoparticles with immune checkpoint inhibitors demonstrates to nearly fully eradicate a colorectal tumor inside the mouse model by chemotherapy and immunotherapy using the STING pathway.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: interferon and immune responses · RNA modifications and cancer · Inflammasome and immune disorders

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Affiliated Hospital of Xiangnan University Chenzhou Hunan Province 423000 China

Xiangnan University Chenzhou Hunan Province 423000 China

Key Laboratory of Medical Imaging and Artificial Intelligence of Hunan Province Chenzhou Hunan Province 423000 China

Hunan Engineering Research Center of Advanced Embedded Computing and Intelligent Medical Systems, Xiangnan University Chenzhou Hunan Province 423000 China

Beijing National Laboratory for Molecular Sciences State Key Laboratory of Polymer Physics and Chemistry Institute of Chemistry Chinese Academy of Sciences Beijing 100190 China

Faculty of Chemistry and Biochemistry Ruhr‐University Bochum Universitätsstrasse 150 44780 Bochum Germany

Funding

Health Commission of Hunan Province

References (51)

Show source-provided references
1. 10.1038/s41423-020-0488-610.1038/s41423-020-0488-6 ↗
2. 10.1002/anie.20220148610.1002/anie.202201486 ↗
3. 10.1038/s41392-021-00827-610.1038/s41392-021-00827-6 ↗
4. 10.1002/adma.20180332210.1002/adma.201803322 ↗
5. 10.1002/adma.20200205410.1002/adma.202002054 ↗
6. 10.1186/s12943-020-01250-110.1186/s12943-020-01250-1 ↗
7. 10.1002/adtp.20220004010.1002/adtp.202200040 ↗
8. 10.1016/j.ijbiomac.2020.01.01510.1016/j.ijbiomac.2020.01.015 ↗
9. 10.1038/nature0847610.1038/nature08476 ↗
10. 10.1038/nsmb.233110.1038/nsmb.2331 ↗
11. 10.1016/j.immuni.2014.10.01910.1016/j.immuni.2014.10.019 ↗
12. 10.1126/science.122996310.1126/science.1229963 ↗
13. 10.1038/nature2347010.1038/nature23470 ↗
14. 10.1038/s41467-018-06922-710.1038/s41467-018-06922-7 ↗
15. 10.1038/nchembio.166110.1038/nchembio.1661 ↗
16. 10.1038/s41551-020-00675-910.1038/s41551-020-00675-9 ↗
17. 10.1038/s41467-020-19651-710.1038/s41467-020-19651-7 ↗
18. 10.1021/acs.accounts.9b0008010.1021/acs.accounts.9b00080 ↗
19. 10.1016/j.molcel.2013.05.02210.1016/j.molcel.2013.05.022 ↗
20. 10.1016/j.immuni.2012.03.01910.1016/j.immuni.2012.03.019 ↗
21. 10.1038/ncomms952410.1038/ncomms9524 ↗
22. 10.1038/nnano.2017.5210.1038/nnano.2017.52 ↗
23. 10.1002/adfm.20160296310.1002/adfm.201602963 ↗
24. 10.1016/j.nantod.2021.10128810.1016/j.nantod.2021.101288 ↗
25. 10.1517/13543776.2015.108116810.1517/13543776.2015.1081168 ↗
26. 10.1038/s41586-019-1000-210.1038/s41586-019-1000-2 ↗
27. 10.1038/srep1904910.1038/srep19049 ↗
28. 10.1038/ncomms1193210.1038/ncomms11932 ↗
29. 10.1038/s41586-022-04559-710.1038/s41586-022-04559-7 ↗
30. 10.1038/s41586-018-0287-810.1038/s41586-018-0287-8 ↗
31. 10.3390/cancers1311269510.3390/cancers13112695 ↗
32. 10.1186/s12943-019-1087-y10.1186/s12943-019-1087-y ↗
33. 10.1021/jacs.9b1031910.1021/jacs.9b10319 ↗
34. 10.1016/j.jbc.2021.10063310.1016/j.jbc.2021.100633 ↗
35. 10.1038/s12276-020-0375-310.1038/s12276-020-0375-3 ↗
36. 10.1158/2326-6066.CIR-21-045910.1158/2326-6066.CIR-21-0459 ↗
37. 10.4331/wjbc.v6.i4.28110.4331/wjbc.v6.i4.281 ↗
38. 10.1038/s41416-020-01156-110.1038/s41416-020-01156-1 ↗
39. 10.1158/0008-5472.CAN-14-149110.1158/0008-5472.CAN-14-1491 ↗
40. 10.1016/j.cell.2016.09.03110.1016/j.cell.2016.09.031 ↗
41. 10.1126/science.125947210.1126/science.1259472 ↗
42. 10.1073/pnas.172094811510.1073/pnas.1720948115 ↗
43. 10.1038/nri.2017.10810.1038/nri.2017.108 ↗
44. 10.3389/fcell.2018.0003810.3389/fcell.2018.00038 ↗
45. 10.1111/imr.1253110.1111/imr.12531 ↗
46. 10.3389/fonc.2018.0000310.3389/fonc.2018.00003 ↗
47. 10.1038/s41467-021-23164-210.1038/s41467-021-23164-2 ↗
48. 10.1038/s41587-020-0462-y10.1038/s41587-020-0462-y ↗
49. 10.1038/s41586-020-2246-410.1038/s41586-020-2246-4 ↗
50. 10.1146/annurev-immunol-042718-04171710.1146/annurev-immunol-042718-041717 ↗
51. 10.1186/s12943-020-01234-110.1186/s12943-020-01234-1 ↗